Articles dans des revues avec comité de lecture (170)
138.
Piagnerelli, M., Zouaoui Boudjeltia, K., Gulbis, B., Vanhaeverbeek, M., & Vincent, J. L. (2007). Anemia in sepsis: the importance of red blood cell membrane changes. TATM. Transfusion alternatives in tranfusion medicine, 9(3), 143-149. doi:10.1111/j.1778-428X.2007.00072.x139.
Van Antwerpen, P., Dufrasne, F., Lequeux, M., Zouaoui Boudjeltia, K., Lessgyer, I., Babar, S., Moreau, P., Moguilevsky, N., Vanhaeverbeek, M., Ducobu, J., & Neve, J. (2007). Inhibition of the myeloperoxidase chlorinating activity by non-steroidal anti-inflammatory drugs: flufenamic acid and its 5-chloro-derivative directly interact with a recombinant human myeloperoxidase to inhibit the synthesis of hypochlorous acid. European journal of pharmacology, 570(1-3), 235-243. doi:10.1016/j.ejphar.2007.05.057140.
Piagnerelli, M., Zouaoui Boudjeltia, K., Brohée, D., Vereerstraeten, A., Piro, P., Vincent, J. L., & Vanhaeverbeek, M. (2007). Assessment of erythrocyte shape by flow cytometry techniques. Journal of Clinical Pathology, 60(5), 549-554. doi:10.1136/jcp.2006.037523141.
Kerkhofs, M., Zouaoui Boudjeltia, K., Stenuit, P., Brohée, D., Cauchie, P., & Vanhaeverbeek, M. (2007). Sleep restriction increases blood neutrophils, total cholesterol and low density lipoprotein cholesterol in postmenopausal women: A preliminary study. Maturitas, 56(2), 212-215. doi:10.1016/j.maturitas.2006.07.007142.
Van Antwerpen, P., Neve, J., Moreau, P., Zouaoui Boudjeltia, K., Vanhaeverbeek, M., Prévost, M., Babar, S., Legssyer, I., Moguilevsky, N., & Ducobu, J. (2007). Probucol does not inhibit myeloperoxidase-dependent low-density lipoprotein oxidation as a potent protective effect in atherosclerosis. Journal of cardiovascular pharmacology, 50, 350-351.143.
Zouaoui Boudjeltia, K., Roumeguere, T., Delree, P., Moguilevsky, N., Ducobu, J., Vanhaeverbeek, M., & Wespes, E. (2007). Presence of LDL Modified by Myeloperoxidase in the Penis in Patients with Vascular Erectile Dysfunction: A Preliminary Study. European urology, 51(1), 262-269. doi:10.1016/j.eururo.2006.08.040144.
Zouaoui Boudjeltia, K., Legssyer, I., Van Antwerpen, P., Lema Kisoka, R., Babar, S., Moguilevsky, N., Delree, P., Ducobu, J., Remacle, C., Vanhaeverbeek, M., & Brohée, D. (2006). Triggering of inflammatory response by myeloperoxidase-oxidized LDL. Biochemistry and cell biology, 84(5), 805-812. doi:10.1139/o06-061145.
Prévot, P.-P., Adam, B., Zouaoui Boudjeltia, K., Brossard, M., Lins, L., Cauchie, P., Brasseur, R., Vanhaeverbeek, M., Vanhamme, L., & Godfroid, E. (2006). Anti-hemostatic effects of a serpin from the saliva of the tick Ixodes ricinus. The Journal of biological chemistry, 281(36), 26361-26369. doi:10.1074/jbc.M604197200146.
Zouaoui Boudjeltia, K., Gregoir, C., Guillaume, M., Remacle, C., Piro, P., Garbar, C., Ducobu, J., Moguilevsky, N., Vanhaeverbeek, M., Delree, P., & Brohée, D. (2006). Antigens and granularity of blood monocytes in relation to inflammatory markers and lipids in postmenopausal women. Maturitas, 55(2), 132-141. doi:10.1016/j.maturitas.2005.12.009147.
Van Antwerpen, P., Zouaoui Boudjeltia, K., Vaes, M., Babar, S., Madhoun, P., Moguilevsky, N., Vanhaeverbeek, M., Neve, J., & Ducobu, J. (2006). The pleiotropic effect of statins in haemodialysis patients is not the consequence of an inhibition of LDL oxidation by myeloperoxidase. Nephrology, dialysis, transplantation, 21(9), 2672-2674. doi:10.1093/ndt/gfl143148.
Cauchie, P., Cauchie, C., Zouaoui Boudjeltia, K., Carlier, E., Deschepper, N., Govaerts, D., Migaud-Fressart, M., Woodhams, B., & Brohée, D. (2006). Diagnosis and prognosis of overt disseminated intravascular coagulation in a general hospital -- meaning of the ISTH score system, fibrin monomers, and lipoprotein-C-reactive protein complex formation. American journal of hematology, 81(6), 414-419. doi:10.1002/ajh.20597149.
Van Antwerpen, P., Legssyer, I., Zouaoui Boudjeltia, K., Babar, S., Moreau, P., Moguilevsky, N., Vanhaeverbeek, M., Ducobu, J., & Neve, J. (2006). Captopril inhibits the oxidative modification of apolipoprotein B-100 caused by myeloperoxydase in a comparative in vitro assay of angiotensin converting enzyme inhibitors. European journal of pharmacology, 537(1-3), 31-36. doi:10.1016/j.ejphar.2006.03.022